CD8A and neoplasm: Taken together, our results suggest that necroptosis or pyroptosis molecules take part in the long-lasting, fine-tuned CD8+ T cell-mediated anti-tumor activity of the recombinant Listeria monocytogenes vaccine, but the deficiency of these molecules can be circumvented by increasing vaccine concentration and perhaps adding a second or third boosting dose.